
Risk factors for secondary infection in the treatment with anti-neutrophil cytoplasmic antibody-associated vasculitis
Risk factors for secondary infection in the treatment with anti-neutrophil cytoplasmic antibody-associated vasculitis
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |